Open Access 10-04-2024 | Hepatitis C | Correction
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis
Published in: Advances in Therapy | Issue 6/2024
Login to get access